Defense Stock Domin...
Health Care: Drugs
Myrexis Inc. (MYRX: OTC)
$0.07 0.00 | 0.00%
05/23/13 - 03:44 PM ET
94.25K / 344.80K
Vol / Avg. Vol:0.07 / 0.07
Open / Prev. Close:0.06 - 0.07
Today's Range:0.06 - 3.02
52 Wk Range:4.95%
Performance YTD:TheStreet Rating:
Portfolios with MYRX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- Usertesting
- ContributorBarron's Activist Stocks 1-...
Latest MYRX Headlines from TheStreet
- Myrexis, Inc. Announces The Cancellation Of Its Upcoming Shareholder Meeting 01.23.13 | 09:01 am
- Lockheed Martin, Myrexis: After-Hours Trading 11.09.12 | 05:11 pm
- 4 Stocks Under $10 Showing Strength in a Weak Market 10.23.12 | 02:10 pm
- Myrexis Reports Fiscal Year 2012 Results And Provides Company Update 09.13.12 | 04:09 pm
- 5 Stocks With Huge Insider Buying 12.01.11 | 06:12 am
- Myrexis Inc. Stock Downgraded (MYRX) 06.17.11 | 07:06 am
- Myrexis Inc. Stock Upgraded (MYRX) 04.20.11 | 06:04 pm
- Myrexis Reorganizes To Align Resources With Current Pipeline 03.29.11 | 12:03 pm
- Myrexis To Provide Update On Heat Shock Protein 90 And Cancer Metabolism Inhibitor Programs At 102nd Annual Meeting Of American Association For Cancer Research 03.17.11 | 04:03 pm
- Myrexis To Present At 10th Annual Needham Healthcare Conference 03.16.11 | 04:03 pm
Press Releases for MYRX
Partner Headlines for MYRX
- Insider Buying And Shareholder Activism Point To Myrexis' Value - Seeking Alpha 01.18.12 | 08:01 am
- Myrexis Appoints Jason M. Aryeh to its Board of Directors - Benzinga 10.20.11 | 04:10 pm
- Rodman & Renshaw Reiterates Myrexis Market Outperform, $6 PT - Benzinga 09.09.11 | 09:09 am
- 16 Small Caps With Cash to Cover 1+ Years of Operating Expenses - Seeking Alpha 04.20.11 | 04:04 am
- What Lies Ahead for Javelin Pharmaceuticals? - Seeking Alpha 06.06.10 | 04:06 am
- Hospira-Javelin Merger in Trouble - Analyst Blog - Zacks 06.04.10 | 03:06 pm
- 6 Ways to Trade FDA and Clinical Trial News - Seeking Alpha 05.28.10 | 02:05 pm
- Hospira Extends Javelin Offer - Analyst Blog - Zacks 05.20.10 | 01:05 pm
- FDA, Clinical Trial News: Discovery Labs, Hospira, Javelin Pharma - Seeking Alpha 05.20.10 | 06:05 am
- Hospira to Acquire Javelin Pharma - Analyst Blog - Zacks 04.20.10 | 04:04 pm
